These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 27600119)
1. Analgesic effects of 1,2,3,4,6-penta-O-galloyl-β-D-glucose in an animal model of lipopolysaccharide-induced pain. Chun K; Kim SO; Lee SH Int J Mol Med; 2016 Oct; 38(4):1264-70. PubMed ID: 27600119 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1,2,3,4,6-penta-O-galloyl-beta-D-glucose in murine macrophage cells. Lee SJ; Lee IS; Mar W Arch Pharm Res; 2003 Oct; 26(10):832-9. PubMed ID: 14609132 [TBL] [Abstract][Full Text] [Related]
3. Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways. Jang SE; Hyam SR; Jeong JJ; Han MJ; Kim DH Br J Pharmacol; 2013 Nov; 170(5):1078-91. PubMed ID: 23941302 [TBL] [Abstract][Full Text] [Related]
4. Anti-metastatic effects of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose in colorectal cancer: Regulation of cathepsin B-mediated extracellular matrix dynamics and epithelial-to-mesenchymal transition. Yang H; Yue GG; Leung PC; Wong CK; Zhang YJ; Lau CB Pharmacol Res; 2022 Oct; 184():106457. PubMed ID: 36116708 [TBL] [Abstract][Full Text] [Related]
5. 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose increases a population of T regulatory cells and inhibits IgE production in ovalbumin-sensitized mice. Kim YH; Yang X; Yamashita S; Kumazoe M; Huang Y; Nakahara K; Won YS; Murata M; Lin IC; Tachibana H Int Immunopharmacol; 2015 May; 26(1):30-6. PubMed ID: 25737197 [TBL] [Abstract][Full Text] [Related]
6. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice. Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245 [TBL] [Abstract][Full Text] [Related]
7. The attenuating effects of 1,2,3,4,6 penta-O-galloyl-β-d-glucose on inflammatory cytokines release from activated BV-2 microglial cells. Mendonca P; Taka E; Bauer D; Cobourne-Duval M; Soliman KF J Neuroimmunol; 2017 Apr; 305():9-15. PubMed ID: 28284353 [TBL] [Abstract][Full Text] [Related]
8. Anti-cancer gallotannin penta-O-galloyl-beta-D-glucose is a nanomolar inhibitor of select mammalian DNA polymerases. Mizushina Y; Zhang J; Pugliese A; Kim SH; Lü J Biochem Pharmacol; 2010 Oct; 80(8):1125-32. PubMed ID: 20599777 [TBL] [Abstract][Full Text] [Related]
9. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Hu H; Lee HJ; Jiang C; Zhang J; Wang L; Zhao Y; Xiang Q; Lee EO; Kim SH; Lü J Mol Cancer Ther; 2008 Sep; 7(9):2681-91. PubMed ID: 18790750 [TBL] [Abstract][Full Text] [Related]
10. The hydrolyzable gallotannin, penta-O-galloyl-β-D-glucopyranoside, inhibits the formation of advanced glycation endproducts by protecting protein structure. Ma H; Liu W; Frost L; Wang L; Kong L; Dain JA; Seeram NP Mol Biosyst; 2015 May; 11(5):1338-47. PubMed ID: 25789915 [TBL] [Abstract][Full Text] [Related]
11. Vasodilatory and anti-inflammatory effects of the 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG) via a nitric oxide-cGMP pathway. Kang DG; Moon MK; Choi DH; Lee JK; Kwon TO; Lee HS Eur J Pharmacol; 2005 Nov; 524(1-3):111-9. PubMed ID: 16253226 [TBL] [Abstract][Full Text] [Related]
12. Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. Huh JE; Lee EO; Kim MS; Kang KS; Kim CH; Cha BC; Surh YJ; Kim SH Carcinogenesis; 2005 Aug; 26(8):1436-45. PubMed ID: 15845650 [TBL] [Abstract][Full Text] [Related]
13. Penta-o-galloyl-beta-d-Glucose (PGG) inhibits inflammation in human rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis model. Umar S; Singh AK; Chourasia M; Rasmussen SM; Ruth JH; Ahmed S Front Immunol; 2022; 13():928436. PubMed ID: 36032089 [TBL] [Abstract][Full Text] [Related]
14. Glucose- and Triglyceride-lowering Dietary Penta-O-galloyl-α-D-Glucose Reduces Expression of PPARγ and C/EBPα, Induces p21-Mediated G1 Phase Cell Cycle Arrest, and Inhibits Adipogenesis in 3T3-L1 Preadipocytes. Liu X; Malki A; Cao Y; Li Y; Qian Y; Wang X; Chen X Exp Clin Endocrinol Diabetes; 2015 May; 123(5):308-16. PubMed ID: 25988880 [TBL] [Abstract][Full Text] [Related]
15. Oral administration of penta-O-galloyl-β-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition. Lee HJ; Seo NJ; Jeong SJ; Park Y; Jung DB; Koh W; Lee HJ; Lee EO; Ahn KS; Ahn KS; Lü J; Kim SH Carcinogenesis; 2011 Jun; 32(6):804-11. PubMed ID: 21289371 [TBL] [Abstract][Full Text] [Related]
16. 1,2,3,4,6-Penta-O-galloyl-β-d-glucose modulates perivascular inflammation and prevents vascular dysfunction in angiotensin II-induced hypertension. Mikolajczyk TP; Nosalski R; Skiba DS; Koziol J; Mazur M; Justo-Junior AS; Kowalczyk P; Kusmierczyk Z; Schramm-Luc A; Luc K; Maffia P; Graham D; Kiss AK; Naruszewicz M; Guzik TJ Br J Pharmacol; 2019 Jun; 176(12):1951-1965. PubMed ID: 30658013 [TBL] [Abstract][Full Text] [Related]
17. Biological and biomedical functions of Penta-O-galloyl-D-glucose and its derivatives. Cao Y; Himmeldirk KB; Qian Y; Ren Y; Malki A; Chen X J Nat Med; 2014 Jul; 68(3):465-72. PubMed ID: 24532420 [TBL] [Abstract][Full Text] [Related]
18. The attenuating effects of 1,2,3,4,6 penta-O-galloyl-β-d-glucose on pro-inflammatory responses of LPS/IFNγ-activated BV-2 microglial cells through NFƙB and MAPK signaling pathways. Mendonca P; Taka E; Bauer D; Reams RR; Soliman KFA J Neuroimmunol; 2018 Nov; 324():43-53. PubMed ID: 30236786 [TBL] [Abstract][Full Text] [Related]
19. 1,2,3,4,6-Penta-O-galloyl-d-glucose Interrupts the Early Adipocyte Lifecycle and Attenuates Adiposity and Hepatic Steatosis in Mice with Diet-Induced Obesity. Sathyanarayana AR; Lu CK; Liaw CC; Chang CC; Han HY; Green BD; Huang WJ; Huang C; He WD; Lee LC; Liu HK Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409415 [TBL] [Abstract][Full Text] [Related]
20. 1,2,3,4,6-Penta-O-galloyl-β-d-glucose suppresses colon cancer through induction of tumor suppressor. Kawk SH; Kang YR; Kim YH Bioorg Med Chem Lett; 2018 Jul; 28(12):2117-2123. PubMed ID: 29778287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]